As the most populated Persian
Gulf country in West Asia, methamphetamine use in methadone maintenance
treatment (MMT) is a new health concern in Iran. Methamphetamine use in MMT can
originate in methadone misconceptions or the stimulant effects of
methamphetamine use.
Several research studies have highlighted the prevalence
of methamphetamine use in Iran and conducting further studies on this issue is
being developed. Opiate use is treated with MMT. But, there is no effective
pharmacological treatment for methamphetamine use and cognitive-behavioral
interventions have still remained the best practice. As a psychostimulant drug,
methamphetamine use can lead to poor treatment outcomes or even treatment
failure among patients in MMT.
Therefore, the implementation of methamphetamine
education and prevention programs in MMT is required. Prescribing adequate
methadone dose and the treatment of comorbidities as well as, doing a series of
activities outside treatment is underscored. Methamphetamine use has a chronic
nature and methamphetamine treatment is a long-term procedure with a high rate
of relapse. Therefore, the implementation of long-term motivational
interviewing, teaching necessary skills to prevent relapse and case management
is highlighted.
A long-term collaboration between treatment teams, patients and
their families is suggested to manage methamphetamine use in MMT.
Full article at: http://goo.gl/2RZFT3
- 1Program of International Research and Training, National Drug and Alcohol Research Centre, Faculty of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.
- 2Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. Mohammad@TUMS.Ac.Ir.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment